Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Moore Wallace was a prominent provider of business communication and information management services, with a significant focus on the healthcare and life sciences industries. The company specialized in clinical trial labeling, patient recruitment materials, and regulatory document management, ensuring compliance and efficiency for pharmaceutical clients. Formed by the 2003 merger of Moore Corporation and Wallace Computer Services, it became a leading vendor for the global clinical supply chain. Its expertise in secure, regulated printing made it a critical partner for managing complex clinical trials and patient communications. In 2004, the company was acquired by RR Donnelley (RRD) for approximately $2.8 billion, integrating its specialized healthcare capabilities into RRD's global Life Sciences division.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Moore Wallace.